id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02882802 | ,43:47:chronic_disease | participants with sub-syndromal levels of PTSD will also be allowed to participate | 2 | [
"participants",
"with",
"sub-syndromal",
"levels",
"of",
"PTSD",
"will",
"also",
"be",
"allowed",
"to",
"participate"
] | [
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02570984 | 60:66:chronic_disease | first degree relative with history or current diagnosis of asthma or allergy | 2 | [
"first",
"degree",
"relative",
"with",
"history",
"or",
"current",
"diagnosis",
"of",
"asthma",
"or",
"allergy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0
] |
NCT03085095 | 118:125:treatment,127:144:treatment,146:157:treatment,212:240:treatment | Evidence of biochemical (PSA) or clinical relapse following local primary intervention with curative intent, such as surgery, radiation therapy, cryotherapy, or high-frequency ultrasound and not a candidate for salvage treatment by surgery | 2 | [
"Evidence",
"of",
"biochemical",
"(",
"PSA",
")",
"or",
"clinical",
"relapse",
"following",
"local",
"primary",
"intervention",
"with",
"curative",
"intent",
",",
"such",
"as",
"surgery",
",",
"radiation",
"therapy",
",",
"cryotherapy",
",",
"or",
"high-frequenc... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02006069 | 1:22:chronic_disease | Myocardial Infarction | 2 | [
"Myocardial",
"Infarction"
] | [
2,
2
] |
NCT02180412 | 9:24:chronic_disease,128:137:treatment,151:163:treatment | Type of acute porphyria confirmed by additional testing (in addition to increased PBG), which may be completed before or after treatment begins using pretreatment samples | 2 | [
"Type",
"of",
"acute",
"porphyria",
"confirmed",
"by",
"additional",
"testing",
"(",
"in",
"addition",
"to",
"increased",
"PBG",
")",
",",
"which",
"may",
"be",
"completed",
"before",
"or",
"after",
"treatment",
"begins",
"using",
"pretreatment",
"samples"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0
] |
NCT02588612 | 74:77:treatment,175:185:treatment,196:226:treatment | Subjects with known epidermal growth factor receptor (EGFR) mutations or ALK or ROS1 gene rearrangements must have failed (disease progression [PD] or unacceptable toxicity) prior EGFR or ALK or ROS1 tyrosine kinase inhibitor, respectively (PD or unacceptable toxicity) | 2 | [
"Subjects",
"with",
"known",
"epidermal",
"growth",
"factor",
"receptor",
"(",
"EGFR",
")",
"mutations",
"or",
"ALK",
"or",
"ROS1",
"gene",
"rearrangements",
"must",
"have",
"failed",
"(",
"disease",
"progression",
"[",
"PD",
"]",
"or",
"unacceptable",
"toxici... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02105766 | ,,103:113:treatment, | Red cell alloimmunization/ Transfusion dependent/ Total hemoglobin increases less than 1g/dL while on hydroxurea (hydroxurea for at least 6 months) | 2 | [
"Red",
"cell",
"alloimmunization/",
"Transfusion",
"dependent/",
"Total",
"hemoglobin",
"increases",
"less",
"than",
"1g/dL",
"while",
"on",
"hydroxurea",
"(",
"hydroxurea",
"for",
"at",
"least",
"6",
"months",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02342782 | 1:40:chronic_disease | psychosocial circumstances or illnesses that preclude protocol participation (to be determined by P.I.) | 2 | [
"psychosocial",
"circumstances",
"or",
"illnesses",
"that",
"preclude",
"protocol",
"participation",
"(",
"to",
"be",
"determined",
"by",
"P.I",
".",
")"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02389517 | 28:40:treatment,, | Patients must be receiving lenalidomide 10 mg or 15 mg and be able to tolerate dose escalation to 25 mg daily | 2 | [
"Patients",
"must",
"be",
"receiving",
"lenalidomide",
"10",
"mg",
"or",
"15",
"mg",
"and",
"be",
"able",
"to",
"tolerate",
"dose",
"escalation",
"to",
"25",
"mg",
"daily"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02943408 | 7:57:chronic_disease | other specified or unspecified depressive disorder (311) | 2 | [
"other",
"specified",
"or",
"unspecified",
"depressive",
"disorder",
"(",
"311",
")"
] | [
0,
2,
2,
2,
2,
2,
2,
0,
0
] |
NCT02940288 | 1:18:chronic_disease | Bleeding disorder | 2 | [
"Bleeding",
"disorder"
] | [
2,
2
] |
NCT02146924 | 32:48:treatment,50:61:treatment,63:72:treatment,74:83:treatment,87:98:treatment | Any known contraindications to cyclophosphamide, fludarabine, etoposide, cetuximab or tocilizumab | 2 | [
"Any",
"known",
"contraindications",
"to",
"cyclophosphamide",
",",
"fludarabine",
",",
"etoposide",
",",
"cetuximab",
"or",
"tocilizumab"
] | [
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT03085004 | 1:6:chronic_disease | Cysts with the following high risk features | 2 | [
"Cysts",
"with",
"the",
"following",
"high",
"risk",
"features"
] | [
2,
0,
0,
0,
0,
0,
0
] |
NCT03137121 | 48:65:cancer | Have histologically or cytologically-confirmed malignant disease in an advanced incurable stage | 2 | [
"Have",
"histologically",
"or",
"cytologically-confirmed",
"malignant",
"disease",
"in",
"an",
"advanced",
"incurable",
"stage"
] | [
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0
] |
NCT01494662 | 41:44:treatment,62:71:treatment,73:81:treatment | Patients with known contraindication to MRI, such as cardiac pacemaker, shrapnel, or ocular foreign body | 2 | [
"Patients",
"with",
"known",
"contraindication",
"to",
"MRI",
",",
"such",
"as",
"cardiac",
"pacemaker",
",",
"shrapnel",
",",
"or",
"ocular",
"foreign",
"body"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0
] |
NCT02543723 | 14:18:treatment | New cycle of OCAs | 2 | [
"New",
"cycle",
"of",
"OCAs"
] | [
0,
0,
0,
1
] |
NCT03137758 | 10:32:treatment,55:59:cancer,63:67:cancer,, | received cytotoxic chemotherapy for either metastatic HSPC or CRPC within the last 12 weeks or other investigational agents within 4 weeks | 2 | [
"received",
"cytotoxic",
"chemotherapy",
"for",
"either",
"metastatic",
"HSPC",
"or",
"CRPC",
"within",
"the",
"last",
"12",
"weeks",
"or",
"other",
"investigational",
"agents",
"within",
"4",
"weeks"
] | [
0,
1,
1,
0,
0,
0,
3,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02056873 | 50:53:treatment,57:79:cancer,120:140:treatment | Any previous neurological intervention including DBS or ablative brain lesions, any metal in the head, and any type of implanted stimulator | 2 | [
"Any",
"previous",
"neurological",
"intervention",
"including",
"DBS",
"or",
"ablative",
"brain",
"lesions",
",",
"any",
"metal",
"in",
"the",
"head",
",",
"and",
"any",
"type",
"of",
"implanted",
"stimulator"
] | [
0,
0,
0,
0,
0,
1,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02401347 | 52:59:allergy_name | Known hypersensitivity to any of the components of BMN 673 | 2 | [
"Known",
"hypersensitivity",
"to",
"any",
"of",
"the",
"components",
"of",
"BMN",
"673"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
4,
4
] |
NCT02565901 | 25:52:treatment | Agree to participate in biopsy of metastatic lesion during the study at day 21 | 2 | [
"Agree",
"to",
"participate",
"in",
"biopsy",
"of",
"metastatic",
"lesion",
"during",
"the",
"study",
"at",
"day",
"21"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02535312 | 36:45:treatment | for whom the current dose level of cisplatin in combination with pemetrexed is appropriate | 2 | [
"for",
"whom",
"the",
"current",
"dose",
"level",
"of",
"cisplatin",
"in",
"combination",
"with",
"pemetrexed",
"is",
"appropriate"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02346253 | 12:33:treatment,35:68:treatment,73:75:treatment,80:95:cancer | History of radical prostatectomy, external beam radiotherapy (EBRT), or BT for prostate cancer | 2 | [
"History",
"of",
"radical",
"prostatectomy",
",",
"external",
"beam",
"radiotherapy",
"(",
"EBRT",
")",
",",
"or",
"BT",
"for",
"prostate",
"cancer"
] | [
0,
0,
1,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
0,
3,
3
] |
NCT01968590 | 1:26:treatment, | oral or IV glucocorticoid use for over 3 months | 2 | [
"oral",
"or",
"IV",
"glucocorticoid",
"use",
"for",
"over",
"3",
"months"
] | [
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02101034 | 31:53:treatment | Currently receiving any other investigational agents | 2 | [
"Currently",
"receiving",
"any",
"other",
"investigational",
"agents"
] | [
0,
0,
0,
0,
1,
1
] |
NCT02442297 | 20:26:cancer,,,, | HER2 expression in tumors on IHC should be greater than or equal to grade 1 and greater than or equal to 1+ intensity score | 2 | [
"HER2",
"expression",
"in",
"tumors",
"on",
"IHC",
"should",
"be",
"greater",
"than",
"or",
"equal",
"to",
"grade",
"1",
"and",
"greater",
"than",
"or",
"equal",
"to",
"1+",
"intensity",
"score"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03108820 | 35:41:cancer | have a self-reported diagnosis of cancer with short life expectancy | 2 | [
"have",
"a",
"self-reported",
"diagnosis",
"of",
"cancer",
"with",
"short",
"life",
"expectancy"
] | [
0,
0,
0,
0,
0,
3,
0,
0,
0,
0
] |
NCT02222545 | 29:33:chronic_disease,46:50:treatment,62:65:chronic_disease,69:72:chronic_disease | Have a diagnosis of primary aHUS, persistent HSCT-associated TMA or TTP | 2 | [
"Have",
"a",
"diagnosis",
"of",
"primary",
"aHUS",
",",
"persistent",
"HSCT-associated",
"TMA",
"or",
"TTP"
] | [
0,
0,
0,
0,
0,
2,
0,
0,
1,
2,
0,
2
] |
NCT02178566 | 24:41:chronic_disease | Use of antibiotics for COPD exacerbation | 2 | [
"Use",
"of",
"antibiotics",
"for",
"COPD",
"exacerbation"
] | [
0,
0,
0,
0,
2,
2
] |
NCT03170518 | 1:20:chronic_disease, | Severe hypoglycemia within 6 months prior to Day 1 | 2 | [
"Severe",
"hypoglycemia",
"within",
"6",
"months",
"prior",
"to",
"Day",
"1"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02367040 | 1:28:cancer,29:58:cancer,60:63:cancer,64:66:cancer | Lymphoplasmacytoid lymphoma/Waldenström macroglobulinemia (LPL/WM) | 2 | [
"Lymphoplasmacytoid",
"lymphoma/Waldenström",
"macroglobulinemia",
"(",
"LPL/WM",
")"
] | [
3,
3,
3,
0,
3,
0
] |
NCT01293214 | 24:64:treatment, | Willing to comply with extensive post-transplant rehabilitation for a minimum of two years | 2 | [
"Willing",
"to",
"comply",
"with",
"extensive",
"post-transplant",
"rehabilitation",
"for",
"a",
"minimum",
"of",
"two",
"years"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02496611 | 12:26:chronic_disease | History of cholelithiasis | 2 | [
"History",
"of",
"cholelithiasis"
] | [
0,
0,
2
] |
NCT02755116 | 1:16:chronic_disease | Hepatic disease | 2 | [
"Hepatic",
"disease"
] | [
2,
2
] |
NCT01795313 | 34:52:cancer | may have non-bulky, asymptomatic metastatic disease | 2 | [
"may",
"have",
"non-bulky",
",",
"asymptomatic",
"metastatic",
"disease"
] | [
0,
0,
0,
0,
0,
3,
3
] |
NCT02389309 | 1:16:treatment,29:38:treatment,42:54:treatment | prior treatment with either dasatinib or temsirolimus | 2 | [
"prior",
"treatment",
"with",
"either",
"dasatinib",
"or",
"temsirolimus"
] | [
1,
1,
0,
0,
1,
0,
1
] |
NCT02494258 | 50:66:treatment | any investigational agent after the last dose of oral azacitidine administered as part of the parent oral azacitidine study | 2 | [
"any",
"investigational",
"agent",
"after",
"the",
"last",
"dose",
"of",
"oral",
"azacitidine",
"administered",
"as",
"part",
"of",
"the",
"parent",
"oral",
"azacitidine",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01973270 | 20:31:treatment,33:48:treatment,67:76:treatment | Being treated with benztropine, diphenhydramine, or high doses of clozapine | 2 | [
"Being",
"treated",
"with",
"benztropine",
",",
"diphenhydramine",
",",
"or",
"high",
"doses",
"of",
"clozapine"
] | [
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
1
] |
NCT02594384 | 1:27:cancer | mantle cell lymphoma (MCL) | 2 | [
"mantle",
"cell",
"lymphoma",
"(",
"MCL",
")"
] | [
3,
3,
3,
3,
0,
0
] |
NCT02101944 | ,,,,134:159:treatment | Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test with a sensitivity of at least 50 mIU/mL prior to starting therapy and prior to beginning another cycle | 2 | [
"Females",
"of",
"childbearing",
"potential",
"(",
"FCBP",
")",
"must",
"have",
"a",
"negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"with",
"a",
"sensitivity",
"of",
"at",
"least",
"50",
"mIU/mL",
"prior",
"to",
"starting",
"therapy",
"and",
"prior... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT03158519 | 1:8:chronic_disease | dyspnea requiring oxygen | 2 | [
"dyspnea",
"requiring",
"oxygen"
] | [
2,
0,
0
] |
NCT01802346 | 26:39:cancer,50:70:treatment,72:83:treatment,89:105:treatment,178:201:cancer | Histologically confirmed breast cancer for which chemotherapy with AC (doxorubicin plus cyclophosphamide) is being utilized in the neoadjuvant or adjuvant setting OR metastatic prostate adenocarcinoma for which Docetaxel will be administered | 2 | [
"Histologically",
"confirmed",
"breast",
"cancer",
"for",
"which",
"chemotherapy",
"with",
"AC",
"(",
"doxorubicin",
"plus",
"cyclophosphamide",
")",
"is",
"being",
"utilized",
"in",
"the",
"neoadjuvant",
"or",
"adjuvant",
"setting",
"OR",
"metastatic",
"prostate",
... | [
0,
0,
3,
3,
0,
0,
1,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT02882802 | 35:51:chronic_disease | Participants also must not have a seizure disorder and must not be taking any medications that would affect cognition or behavior on the aggression task, including pain medication | 2 | [
"Participants",
"also",
"must",
"not",
"have",
"a",
"seizure",
"disorder",
"and",
"must",
"not",
"be",
"taking",
"any",
"medications",
"that",
"would",
"affect",
"cognition",
"or",
"behavior",
"on",
"the",
"aggression",
"task",
",",
"including",
"pain",
"medic... | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02480036 | 14:29:chronic_disease,72:88:chronic_disease,102:126:chronic_disease,128:152:chronic_disease,154:172:chronic_disease,177:214:chronic_disease | Uncontrolled medical illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements | 2 | [
"Uncontrolled",
"medical",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"o... | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02138214 | 33:39:cancer | Failure to confirm diagnosis of cancer in participant | 2 | [
"Failure",
"to",
"confirm",
"diagnosis",
"of",
"cancer",
"in",
"participant"
] | [
0,
0,
0,
0,
0,
3,
0,
0
] |
NCT01184547 | 14:20:chronic_disease,24:41:chronic_disease,48:57:chronic_disease,59:63:chronic_disease | Uncontrolled asthma or pulmonary disease (e.g. emphysema, COPD) | 2 | [
"Uncontrolled",
"asthma",
"or",
"pulmonary",
"disease",
"(",
"e.g",
".",
"emphysema",
",",
"COPD",
")"
] | [
0,
2,
0,
2,
2,
0,
0,
0,
2,
0,
2,
0
] |
NCT01366612 | 13:42:chronic_disease,,,, | Evidence of hepatic synthetic dysfunction, or total bilirubin >2x or AST >3x UL | 2 | [
"Evidence",
"of",
"hepatic",
"synthetic",
"dysfunction",
",",
"or",
"total",
"bilirubin",
">",
"2x",
"or",
"AST",
">",
"3x",
"UL"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02343042 | 95:97:cancer | Histologically confirmed diagnosis, measurable disease and evidence of disease progression of MM | 2 | [
"Histologically",
"confirmed",
"diagnosis",
",",
"measurable",
"disease",
"and",
"evidence",
"of",
"disease",
"progression",
"of",
"MM"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02949726 | 55:68:cancer,87:124:treatment,129:148:treatment,175:187:treatment,189:199:treatment,203:228:treatment | Participants must have been clinically diagnosed with breast cancer and scheduled for axillary lymph node dissection (ALND) and radiation treatment at MD Anderson (receiving chemotherapy, mastectomy or breast-conserving surgery | 2 | [
"Participants",
"must",
"have",
"been",
"clinically",
"diagnosed",
"with",
"breast",
"cancer",
"and",
"scheduled",
"for",
"axillary",
"lymph",
"node",
"dissection",
"(",
"ALND",
")",
"and",
"radiation",
"treatment",
"at",
"MD",
"Anderson",
"(",
"receiving",
"che... | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1
] |
NCT02085941 | 1:7:cancer | tumors that encase any major blood vessel (carotid, jugular, vertebral) | 2 | [
"tumors",
"that",
"encase",
"any",
"major",
"blood",
"vessel",
"(",
"carotid",
",",
"jugular",
",",
"vertebral",
")"
] | [
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02426476 | 14:36:chronic_disease,38:54:treatment,56:78:treatment, | a history of ischemic heart disease, heart transplant, cardiovascular surgery within 1 year | 2 | [
"a",
"history",
"of",
"ischemic",
"heart",
"disease",
",",
"heart",
"transplant",
",",
"cardiovascular",
"surgery",
"within",
"1",
"year"
] | [
0,
0,
0,
2,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02633111 | 1:38:cancer,71:106:cancer,111:138:cancer | De novo diffuse large B-cell lymphoma (including all subtypes such as primary mediastinal B-cell lymphoma and T-cell rich B-cell lymphoma) | 2 | [
"De",
"novo",
"diffuse",
"large",
"B-cell",
"lymphoma",
"(",
"including",
"all",
"subtypes",
"such",
"as",
"primary",
"mediastinal",
"B-cell",
"lymphoma",
"and",
"T-cell",
"rich",
"B-cell",
"lymphoma",
")"
] | [
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
3,
3,
3,
3,
0
] |
NCT03037983 | 38:41:allergy_name | History of prior adverse reaction to TMS | 2 | [
"History",
"of",
"prior",
"adverse",
"reaction",
"to",
"TMS"
] | [
0,
0,
0,
0,
0,
0,
4
] |
NCT01954173 | 7:16:chronic_disease,20:36:chronic_disease,47:70:treatment | Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration | 2 | [
"Acute",
"bacterial",
"or",
"fungal",
"infection",
"requiring",
"intravenous",
"antibiotics",
"at",
"the",
"time",
"of",
"registration"
] | [
0,
2,
0,
2,
2,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02548351 | 86:90:treatment,91:101:treatment,105:114:treatment, | For subjects with a historical biopsy, is either not taking or is on stable doses of TZDs/glitazones or vitamin E for 6 months before Day 1 | 2 | [
"For",
"subjects",
"with",
"a",
"historical",
"biopsy",
",",
"is",
"either",
"not",
"taking",
"or",
"is",
"on",
"stable",
"doses",
"of",
"TZDs/glitazones",
"or",
"vitamin",
"E",
"for",
"6",
"months",
"before",
"Day",
"1"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02562430 | 16:32:chronic_disease | any history of seizure disorder | 2 | [
"any",
"history",
"of",
"seizure",
"disorder"
] | [
0,
0,
0,
2,
2
] |
NCT02926378 | 10:30:chronic_disease | Evidence cognitive impairment that would negatively impact capacity to understand and participate in this study | 2 | [
"Evidence",
"cognitive",
"impairment",
"that",
"would",
"negatively",
"impact",
"capacity",
"to",
"understand",
"and",
"participate",
"in",
"this",
"study"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02015390 | 22:42:chronic_disease | Patients with active compartment syndrome | 2 | [
"Patients",
"with",
"active",
"compartment",
"syndrome"
] | [
0,
0,
0,
2,
2
] |
NCT02663908 | 24:58:treatment | Indication to initiate androgen deprivation therapy (ADT) | 2 | [
"Indication",
"to",
"initiate",
"androgen",
"deprivation",
"therapy",
"(",
"ADT",
")"
] | [
0,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT02266745 | 1:26:treatment | immunosuppressive therapy | 2 | [
"immunosuppressive",
"therapy"
] | [
1,
1
] |
NCT02926378 | 1:25:treatment | Magnetic dental implants - loss of magnetic hold to keep the implant in place | 2 | [
"Magnetic",
"dental",
"implants",
"-",
"loss",
"of",
"magnetic",
"hold",
"to",
"keep",
"the",
"implant",
"in",
"place"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02451423 | 12:33:chronic_disease,12:21:treatment,58:66:chronic_disease | History of radiation pneumonitis in the radiation field (fibrosis) is permitted | 2 | [
"History",
"of",
"radiation",
"pneumonitis",
"in",
"the",
"radiation",
"field",
"(",
"fibrosis",
")",
"is",
"permitted"
] | [
0,
0,
1,
2,
0,
0,
0,
0,
0,
2,
0,
0,
0
] |
NCT03119363 | 1:17:cancer, | Secondary cancer diagnosis (prior or current) within the past 5 years | 2 | [
"Secondary",
"cancer",
"diagnosis",
"(",
"prior",
"or",
"current",
")",
"within",
"the",
"past",
"5",
"years"
] | [
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03033212 | 1:22:chronic_disease | degenerative kyphosis | 2 | [
"degenerative",
"kyphosis"
] | [
2,
2
] |
NCT02610374 | 1:25:chronic_disease,34:50:chronic_disease,64:74:cancer,89:110:treatment | Active chronic infection such as hepatitis B or C or an active malignancy that requires systemic chemotherapy | 2 | [
"Active",
"chronic",
"infection",
"such",
"as",
"hepatitis",
"B",
"or",
"C",
"or",
"an",
"active",
"malignancy",
"that",
"requires",
"systemic",
"chemotherapy"
] | [
2,
2,
2,
0,
0,
2,
2,
2,
2,
0,
0,
0,
3,
0,
0,
1,
1
] |
NCT03016351 | 1:10:allergy_name | Lidocaine allergy | 2 | [
"Lidocaine",
"allergy"
] | [
4,
0
] |
NCT01705119 | 9:32:treatment | who are mechanically ventilated | 2 | [
"who",
"are",
"mechanically",
"ventilated"
] | [
0,
0,
1,
1
] |
NCT02091999 | 28:80:treatment | Subject must have received prior treatment with a CPI in the metastatic setting | 2 | [
"Subject",
"must",
"have",
"received",
"prior",
"treatment",
"with",
"a",
"CPI",
"in",
"the",
"metastatic",
"setting"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02128906 | 28:40:treatment,44:53:treatment,89:109:cancer | Patients may have received chemotherapy or radiation for a previous, curatively treated non-HNSCC malignancy | 2 | [
"Patients",
"may",
"have",
"received",
"chemotherapy",
"or",
"radiation",
"for",
"a",
"previous",
",",
"curatively",
"treated",
"non-HNSCC",
"malignancy"
] | [
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT03029884 | 1:4:treatment,,58:65:treatment,74:78:chronic_disease,80:86:chronic_disease,88:98:chronic_disease | MRI done within one year not showing contraindication to surgery such as mass, lesion, hemorrhage or other abnormality near target | 2 | [
"MRI",
"done",
"within",
"one",
"year",
"not",
"showing",
"contraindication",
"to",
"surgery",
"such",
"as",
"mass",
",",
"lesion",
",",
"hemorrhage",
"or",
"other",
"abnormality",
"near",
"target"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
2,
0,
2,
0,
2,
0,
0,
0,
0,
0
] |
NCT03003780 | 19:50:chronic_disease | Clinical signs of unstable cardiovascular disease | 2 | [
"Clinical",
"signs",
"of",
"unstable",
"cardiovascular",
"disease"
] | [
0,
0,
0,
2,
2,
2
] |
NCT01626079 | 1:25:chronic_disease, | Cerebrovascular accident within 30 days prior to subject registration | 2 | [
"Cerebrovascular",
"accident",
"within",
"30",
"days",
"prior",
"to",
"subject",
"registration"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02721381 | 24:36:chronic_disease,44:56:chronic_disease,60:77:chronic_disease | history of significant brain injury, known neurological or genetic condition | 2 | [
"history",
"of",
"significant",
"brain",
"injury",
",",
"known",
"neurological",
"or",
"genetic",
"condition"
] | [
0,
0,
0,
2,
2,
0,
0,
2,
0,
2,
2
] |
NCT02543944 | 1:31:chronic_disease | Wolff-Parkinson White syndrome | 2 | [
"Wolff-Parkinson",
"White",
"syndrome"
] | [
2,
2,
2
] |
NCT02783716 | 26:31:treatment,35:40:treatment,45:63:chronic_disease,,,,,,, | Patients recommended for CRT-P or CRT-D for heart failure (HF) according to current American Heart Association (AHA)/American College of Cardiology (ACC)/Heart Rhythm Society (HRS) guidelines of Left Ventricle Ejection Fraction (LVEF)<35%, Left Bundle Branch Block (LBBB)>120 ms, New York Heart Association (NYHA) Class ... | 2 | [
"Patients",
"recommended",
"for",
"CRT-P",
"or",
"CRT-D",
"for",
"heart",
"failure",
"(",
"HF",
")",
"according",
"to",
"current",
"American",
"Heart",
"Association",
"(",
"AHA",
")",
"/American",
"College",
"of",
"Cardiology",
"(",
"ACC",
")",
"/Heart",
"Rh... | [
0,
0,
0,
1,
0,
1,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT01585402 | 1:24:chronic_disease,, | Severe renal impairment (estimated creatinine clearance/eGFR of < 30ml/min calculated using CKD-EPI equation | 2 | [
"Severe",
"renal",
"impairment",
"(",
"estimated",
"creatinine",
"clearance/eGFR",
"of",
"<",
"30ml/min",
"calculated",
"using",
"CKD-EPI",
"equation"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02226159 | 1:19:chronic_disease | Bleeding disorders or other medical contraindications to the injection procedure | 2 | [
"Bleeding",
"disorders",
"or",
"other",
"medical",
"contraindications",
"to",
"the",
"injection",
"procedure"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02589600 | ,13:25:chronic_disease, | Men because osteoporosis is less common in men | 2 | [
"Men",
"because",
"osteoporosis",
"is",
"less",
"common",
"in",
"men"
] | [
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02520791 | 39:56:chronic_disease,95:101:chronic_disease,105:124:chronic_disease,323:332:chronic_disease,365:374:chronic_disease,520:549:treatment | All potential patients must undergo a tuberculosis (TB) test prior to study entry to rule out active or latent tuberculosis (either purified protein derivative [PPD] or QuantiFERON-TB Gold, whichever is preferred and available at the institution); patients with a history of TB (even if treated), or evidence of active o... | 2 | [
"All",
"potential",
"patients",
"must",
"undergo",
"a",
"tuberculosis",
"(",
"TB",
")",
"test",
"prior",
"to",
"study",
"entry",
"to",
"rule",
"out",
"active",
"or",
"latent",
"tuberculosis",
"(",
"either",
"purified",
"protein",
"derivative",
"[",
"PPD",
"]... | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02262806 | 1:21:chronic_disease | Psychiatric disorder impeding competence or compliance | 2 | [
"Psychiatric",
"disorder",
"impeding",
"competence",
"or",
"compliance"
] | [
2,
2,
0,
0,
0,
0
] |
NCT02319369 | 20:48:cancer | Has a diagnosis of acute promyelocytic leukemia | 2 | [
"Has",
"a",
"diagnosis",
"of",
"acute",
"promyelocytic",
"leukemia"
] | [
0,
0,
0,
0,
3,
3,
3
] |
NCT00713492 | 22:25:treatment | Abnormal findings on ECG, unless cleared for participation by cardiologist or Licensed Independent Practitioner (LIP) | 2 | [
"Abnormal",
"findings",
"on",
"ECG",
",",
"unless",
"cleared",
"for",
"participation",
"by",
"cardiologist",
"or",
"Licensed",
"Independent",
"Practitioner",
"(",
"LIP",
")"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01562626 | 1:5:treatment | 5-FC | 2 | [
"5-FC"
] | [
1
] |
NCT03069469 | 1:51:cancer | Diffuse-type Tenosynovial Giant Cell Tumor (DTGCT) patients | 2 | [
"Diffuse-type",
"Tenosynovial",
"Giant",
"Cell",
"Tumor",
"(",
"DTGCT",
")",
"patients"
] | [
3,
3,
3,
3,
3,
3,
0,
0,
0
] |
NCT02310399 | 14:30:chronic_disease | Severe inner ear malformation | 2 | [
"Severe",
"inner",
"ear",
"malformation"
] | [
0,
0,
2,
2
] |
NCT02555189 | 16:26:treatment | The effects of ribociclib on the developing human fetus at the recommended therapeutic dose are unknown | 2 | [
"The",
"effects",
"of",
"ribociclib",
"on",
"the",
"developing",
"human",
"fetus",
"at",
"the",
"recommended",
"therapeutic",
"dose",
"are",
"unknown"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00169806 | 70:91:treatment,96:111:chronic_disease,121:137:chronic_disease | Patients of Methodist Urology in Indianapolis, IN who are undergoing endoscopic procedures for nephrolithiasis or other urologic disease | 2 | [
"Patients",
"of",
"Methodist",
"Urology",
"in",
"Indianapolis",
",",
"IN",
"who",
"are",
"undergoing",
"endoscopic",
"procedures",
"for",
"nephrolithiasis",
"or",
"other",
"urologic",
"disease"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
2,
0,
0,
2,
2
] |
NCT02140554 | ,,53:72:treatment | abnormal transcranial Doppler [≥200 cm/sec] needing chronic transfusion | 2 | [
"abnormal",
"transcranial",
"Doppler",
"[",
"≥200",
"cm/sec",
"]",
"needing",
"chronic",
"transfusion"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01893554 | 1:5:chronic_disease,9:22:chronic_disease,56:79:chronic_disease | Lung or heart disease, including any wheezing event or reactive airway disease | 2 | [
"Lung",
"or",
"heart",
"disease",
",",
"including",
"any",
"wheezing",
"event",
"or",
"reactive",
"airway",
"disease"
] | [
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02875405 | 1:34:chronic_disease | mitral or tricuspid valve disease | 2 | [
"mitral",
"or",
"tricuspid",
"valve",
"disease"
] | [
2,
2,
2,
2,
2
] |
NCT02353819 | 4:17:cancer | No nodal disease | 2 | [
"No",
"nodal",
"disease"
] | [
0,
3,
3
] |
NCT01986075 | 28:51:treatment | Currently being prescribed psychotropic medication by another physician | 2 | [
"Currently",
"being",
"prescribed",
"psychotropic",
"medication",
"by",
"another",
"physician"
] | [
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT01676259 | 13:49:chronic_disease | symptomatic peripheral arterial vascular disease | 2 | [
"symptomatic",
"peripheral",
"arterial",
"vascular",
"disease"
] | [
0,
2,
2,
2,
2
] |
NCT02111850 | 39:49:treatment,70:81:chronic_disease,101:112:treatment,125:141:treatment | Patients who have previously received ipilimumab and have documented GI toxicity must have a normal colonoscopy with normal colonic biopsies | 2 | [
"Patients",
"who",
"have",
"previously",
"received",
"ipilimumab",
"and",
"have",
"documented",
"GI",
"toxicity",
"must",
"have",
"a",
"normal",
"colonoscopy",
"with",
"normal",
"colonic",
"biopsies"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
2,
2,
0,
0,
0,
0,
1,
0,
0,
1,
1
] |
NCT03169543 | 1:15:chronic_disease | Claustrophobic, or intolerant of the scanner environment | 2 | [
"Claustrophobic",
",",
"or",
"intolerant",
"of",
"the",
"scanner",
"environment"
] | [
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02276443 | ,,69:96:chronic_disease | Patients who have history of PR prolongation (grade 2 or higher) or atrioventricular (AV) block | 2 | [
"Patients",
"who",
"have",
"history",
"of",
"PR",
"prolongation",
"(",
"grade",
"2",
"or",
"higher",
")",
"or",
"atrioventricular",
"(",
"AV",
")",
"block"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0
] |
NCT01037790 | 5:11:cancer | All tumors must test positive for Rb expression | 2 | [
"All",
"tumors",
"must",
"test",
"positive",
"for",
"Rb",
"expression"
] | [
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT02594384 | 15:20:cancer,122:142:treatment,146:168:treatment | Patients with DLBCL: Cancer progression after transplant, or be unwilling, unable or not an appropriate candidate for an autologous stem cell or bone marrow transplant | 2 | [
"Patients",
"with",
"DLBCL",
":",
"Cancer",
"progression",
"after",
"transplant",
",",
"or",
"be",
"unwilling",
",",
"unable",
"or",
"not",
"an",
"appropriate",
"candidate",
"for",
"an",
"autologous",
"stem",
"cell",
"or",
"bone",
"marrow",
"transplant"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
1
] |
NCT02925923 | 1:9:treatment | Edoxaban | 2 | [
"Edoxaban"
] | [
1
] |
NCT02740361 | 1:39:chronic_disease,48:56:chronic_disease,60:66:chronic_disease | substantial neurocognitive impairments such as dementia or autism | 2 | [
"substantial",
"neurocognitive",
"impairments",
"such",
"as",
"dementia",
"or",
"autism"
] | [
2,
2,
2,
0,
0,
2,
0,
2
] |
NCT02433977 | 1:7:chronic_disease, | Asthma-related hospitalization within the last 2 months | 2 | [
"Asthma-related",
"hospitalization",
"within",
"the",
"last",
"2",
"months"
] | [
2,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.